Amgen (AMGN) FCF Payout Ratio (2011 - 2026)
Amgen (AMGN) posted quarterly FCF Payout Ratio of 0.92 for Q1 2026, down 29.55% year-over-year from 1.31 in Q1 2025, and down 31.13% quarter-over-quarter from 1.34 in Q4 2025.
Amgen (AMGN) FCF Payout Ratio (2011 - 2026) Analysis & Trends
Amgen's FCF Payout Ratio history runs 16 years deep, the most recent figure standing at 0.92 for Q1 2026.
- In Q1 2026, FCF Payout Ratio fell 29.55% year-over-year to 0.92; the TTM figure through Mar 2026 stood at 0.61 (up 34.73% YoY), while the FY2025 annual figure was 0.63, up 36.08% from the prior year.
- FCF Payout Ratio for Q1 2026 stood at 0.92, down from 1.34 in the prior quarter.
- The five-year high for FCF Payout Ratio was 3.94 in Q4 2023, with the low at 0.27 in Q4 2024.
- The 5-year median for FCF Payout Ratio is 0.55 (2022), against an average of 0.98.
- The sharpest annual moves came in 2023 and 2024: FCF Payout Ratio surged 775.79% in 2023, then sank 93.06% in 2024.
- Amgen's FCF Payout Ratio stood at 0.45 in 2022, then soared by 775.79% to 3.94 in 2023, then tumbled by 93.06% to 0.27 in 2024, then soared by 387.49% to 1.34 in 2025, then tumbled by 31.13% to 0.92 in 2026.
- Business Quant data shows AMGN's FCF Payout Ratio at 0.92 in Q1 2026, 1.34 in Q4 2025, and 0.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.44 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.99 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.48 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.52 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -3.54 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.39 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.30 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 8.12 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.39 |
| Mar 31, 2026 | 0.92 |
| Dec 31, 2025 | 1.34 |
| Sep 30, 2025 | 0.30 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 1.31 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.37 |
| Jun 30, 2024 | 0.54 |
| Mar 31, 2024 | 2.63 |
| Dec 31, 2023 | 3.94 |
| Sep 30, 2023 | 0.45 |
| Jun 30, 2023 | 0.30 |
| Mar 31, 2023 | 1.58 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.37 |
| Jun 30, 2022 | 0.62 |
| Mar 31, 2022 | 0.55 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.46 |